A Münster, Germany-based medical technology company aiming to revolutionize cancer diagnostics has closed a $5.5M Series A funding round. Refined Laser Systems | Refined Diagnostics is developing high-precision laser microscopy that allows for molecular tissue analysis within minutes, directly at the point of care.
This innovative approach empowers surgeons and pathologists to identify cancer cells during surgery, a critical step that could reduce repeat procedures, patient stress, and treatment costs. The company, which has already secured over €10 million in private and public funding, is nearing IVD-A approval after completing its first clinical study.
.png&w=3840&q=75)
